• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三个世界区域冠状动脉疾病风险因素管理的决定因素。

Determinants of coronary artery disease risk factor management across three world regions.

作者信息

Zhao Min, Graham Ian, Cooney Marie Therese, Grobbee Diederick E, Vaartjes Ilonca, Klipstein-Grobusch Kerstin

机构信息

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Trinity College Dublin, Dublin, Ireland.

出版信息

Heart Asia. 2019 Mar 8;11(1):e011112. doi: 10.1136/heartasia-2018-011112. eCollection 2019.

DOI:10.1136/heartasia-2018-011112
PMID:31031827
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6454324/
Abstract

BACKGROUND

The SUrvey of Risk Factors (SURF) indicated poor control of risk factors in subjects with established coronary heart disease (CHD). The present study aimed to investigate determinants of risk factor management in patients with CHD.

METHODS AND RESULTS

SURF recruited 9987 consecutive patients with CHD from Europe, Asia and the Middle East between 2012 and 2013. Risk factor management was summarised as a Cardiovascular Health Index Score (CHIS) based on six risk factor targets (non-smoker/ex-smoker, body mass index <30, adequate exercise, controlled blood pressure, controlled low-density lipoprotein and controlled glucose). Logistic regression models assessed the associations between determinants (age, sex, family history, cardiac rehabilitation, previous hospital admission and diabetes) and achievement of moderate CHIS (≥3 risk factors controlled). The results are presented as OR with corresponding 95% CI. A moderate CHIS was less likely to be reached by women (OR 0.90, 95% CI 0.69 to 1.00), those aged <55 years old (OR 0.62, 95% CI 0.53 to 0.76) and those with diabetes (OR 0.41, 95% CI 0.37 to 0.46). Attendance in cardiac rehabilitation was associated with better CHIS achievements (OR 1.62, 95% CI 1.42 to 1.87). Younger Asian and European patients had poorer risk factor management, whereas for patients from the Middle East age was not significantly associated with risk factor management. The availability and applicability of cardiac rehabilitation varied by region.

CONCLUSIONS

Overall, risk factor management was poorer in women, those younger than 55 years old, those with diabetes and those who did not participate in a cardiac rehabilitation. Determinants of cardiovascular risk factor management differed by region.

摘要

背景

风险因素调查(SURF)表明,已确诊冠心病(CHD)患者的风险因素控制不佳。本研究旨在调查冠心病患者风险因素管理的决定因素。

方法与结果

SURF在2012年至2013年间连续招募了来自欧洲、亚洲和中东的9987例冠心病患者。基于六个风险因素目标(非吸烟者/已戒烟者、体重指数<30、适度运动、血压得到控制、低密度脂蛋白得到控制和血糖得到控制),将风险因素管理总结为心血管健康指数评分(CHIS)。逻辑回归模型评估了决定因素(年龄、性别、家族病史、心脏康复、既往住院和糖尿病)与达到中度CHIS(≥3个风险因素得到控制)之间的关联。结果以OR及相应的95%CI表示。女性(OR 0.90,95%CI 0.69至1.00)、年龄<55岁的患者(OR 0.62,95%CI 0.53至0.76)和糖尿病患者(OR 0.41,95%CI 0.37至0.46)达到中度CHIS的可能性较小。参加心脏康复与更好的CHIS成绩相关(OR 1.62,95%CI 1.42至1.87)。亚洲和欧洲的年轻患者风险因素管理较差,而中东患者的年龄与风险因素管理无显著关联。心脏康复的可及性和适用性因地区而异。

结论

总体而言,女性、年龄小于55岁的患者、糖尿病患者以及未参加心脏康复的患者的风险因素管理较差。心血管风险因素管理的决定因素因地区而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e19/6454324/f83ee76ed212/heartasia-2018-011112f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e19/6454324/3abbbeac1bbd/heartasia-2018-011112f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e19/6454324/f83ee76ed212/heartasia-2018-011112f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e19/6454324/3abbbeac1bbd/heartasia-2018-011112f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e19/6454324/f83ee76ed212/heartasia-2018-011112f02.jpg

相似文献

1
Determinants of coronary artery disease risk factor management across three world regions.三个世界区域冠状动脉疾病风险因素管理的决定因素。
Heart Asia. 2019 Mar 8;11(1):e011112. doi: 10.1136/heartasia-2018-011112. eCollection 2019.
2
Sex differences in risk factor management of coronary heart disease across three regions.三个地区冠心病危险因素管理中的性别差异。
Heart. 2017 Oct;103(20):1587-1594. doi: 10.1136/heartjnl-2017-311429. Epub 2017 Sep 20.
3
SURF - SUrvey of Risk Factor management: first report of an international audit.SURF-风险因素管理调查:国际审计的第一份报告。
Eur J Prev Cardiol. 2014 Jul;21(7):813-22. doi: 10.1177/2047487312467870. Epub 2012 Nov 12.
4
Risk factors in cardiovascular patients: Challenges and opportunities to improve secondary prevention.心血管疾病患者的风险因素:改善二级预防的挑战与机遇
World J Cardiol. 2023 Jul 26;15(7):342-353. doi: 10.4330/wjc.v15.i7.342.
5
Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.简化风险因素记录与控制的审核:一项在11个国家开展的国际研究报告
Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.
6
Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.依据欧洲冠心病患者参加心脏康复项目的情况评估其参与度和危险因素控制情况的决定因素:EUROASPIRE IV 调查。
Eur J Prev Cardiol. 2018 Aug;25(12):1242-1251. doi: 10.1177/2047487318781359. Epub 2018 Jun 6.
7
Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East.中东地区急性冠脉综合征患者中心血管危险因素的流行情况及其影响。
Clin Cardiol. 2011 Jan;34(1):51-8. doi: 10.1002/clc.20873.
8
Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study.观察性 DYSIS II 研究中,在确诊的冠心病中使用指南推荐的治疗方法。
Int J Cardiol. 2018 Nov 1;270:21-27. doi: 10.1016/j.ijcard.2018.06.008. Epub 2018 Jun 6.
9
[An analysis of relationship between the severity of coronary artery lesion and risk factors of cardiovascular events in Tianjin].[天津地区冠状动脉病变严重程度与心血管事件危险因素的关系分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Nov;25(11):650-4. doi: 10.3760/cma.j.issn.2095-4352.2013.11.014.
10
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.

引用本文的文献

1
The Effects of mHealth Interventions on Quality of Life, Anxiety, and Depression in Patients With Coronary Heart Disease: Meta-Analysis of Randomized Controlled Trials.移动医疗干预对冠心病患者生活质量、焦虑和抑郁的影响:随机对照试验的荟萃分析。
J Med Internet Res. 2024 Jun 11;26:e52341. doi: 10.2196/52341.
2
The Effect of Cardiac Rehabilitation on Lipid Levels in Patients with Coronary Heart Disease. A Systematic Review and Meta-Analysis.心脏康复对冠心病患者血脂水平的影响:系统评价和荟萃分析。
Glob Heart. 2022 Nov 29;17(1):83. doi: 10.5334/gh.1170. eCollection 2022.
3
Evaluation of Plasma Asprosin Concentration in Patients with Coronary Artery Disease.

本文引用的文献

1
Cardiac Rehabilitation Models around the Globe.全球范围内的心脏康复模式。
J Clin Med. 2018 Sep 7;7(9):260. doi: 10.3390/jcm7090260.
2
Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study.一般人群心血管危险因素及其决定因素的控制——STAAB队列研究结果
BMC Cardiovasc Disord. 2017 Nov 2;17(1):276. doi: 10.1186/s12872-017-0708-x.
3
Sex differences in risk factor management of coronary heart disease across three regions.三个地区冠心病危险因素管理中的性别差异。
评估冠心病患者血浆天冬酰胺浓度。
Braz J Cardiovasc Surg. 2022 Aug 16;37(4):493-500. doi: 10.21470/1678-9741-2021-0003.
4
The efficacy of mobile health in alleviating risk factors related to the occurrence and development of coronary heart disease: A systematic review and meta-analysis.移动医疗在缓解与冠心病发生发展相关的危险因素方面的疗效:系统评价和荟萃分析。
Clin Cardiol. 2021 May;44(5):609-619. doi: 10.1002/clc.23596. Epub 2021 Mar 16.
Heart. 2017 Oct;103(20):1587-1594. doi: 10.1136/heartjnl-2017-311429. Epub 2017 Sep 20.
4
Impact of cardiac rehabilitation and exercise training programs in coronary heart disease.心脏康复和运动训练计划对冠心病的影响。
Prog Cardiovasc Dis. 2017 Jun-Jul;60(1):103-114. doi: 10.1016/j.pcad.2017.07.002. Epub 2017 Jul 6.
5
Impact of Cardiorespiratory Fitness on All-Cause and Disease-Specific Mortality: Advances Since 2009.心肺适能对全因死亡率和疾病特异性死亡率的影响:2009年以来的进展
Prog Cardiovasc Dis. 2017 Jun-Jul;60(1):11-20. doi: 10.1016/j.pcad.2017.03.001. Epub 2017 Mar 9.
6
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
7
Cardiac Rehabilitation Delivery Model for Low-Resource Settings: An International Council of Cardiovascular Prevention and Rehabilitation Consensus Statement.资源有限环境下的心脏康复服务模式:国际心血管预防与康复协会共识声明。
Prog Cardiovasc Dis. 2016 Nov-Dec;59(3):303-322. doi: 10.1016/j.pcad.2016.08.004. Epub 2016 Aug 17.
8
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
9
Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.简化风险因素记录与控制的审核:一项在11个国家开展的国际研究报告
Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.
10
Knowledge Gaps in Cardiovascular Care of the Older Adult Population: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Geriatrics Society.老年人群心血管护理中的知识空白:美国心脏协会、美国心脏病学会和美国老年医学会的科学声明。
Circulation. 2016 May 24;133(21):2103-22. doi: 10.1161/CIR.0000000000000380. Epub 2016 Apr 11.